ASHLEY CIOCHON: Open Payments
NPI 1467902692 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$174 in 9 payments from 6 companies in 2025. Trend: 2023 $102 · 2024 $140 · 2025 $174
Food & beverage: $174
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| ABIOMED | 1 | $33 |
| ViiV Healthcare Company | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, XIFAXAN, APRETUDE, REXULTI.
Industry payments across NE — which companies pay providers there.
